Quetiapine, Misuse and Dependency: A Case-Series of Questions to a Norwegian Network of Drug Information Centers

References

• Mattson ME, Albright VA, Yoon J, Council CL. Emergency department visits involving misuse and abuse of the antipsychotic quetiapine: results from the drug abuse warning network (DAWN). Subst Abuse. 2015;9:39–46. doi:10.4137/SART.S22233
   PubMed Web of Science ®Google Scholar
• Lee J, Pilgrim J, Gerostamoulos D, Robinson J, Wong A. Increasing rates of quetiapine overdose, misuse, and mortality in Victoria, Australia. Drug Alcohol Depend. 2018;187:95–99. doi:10.1016/j.drugalcdep.2018.03.002
   PubMed Web of Science ®Google Scholar
• Chiappini S, Schifano F. Is there a potential of misuse for quetiapine? Literature review and analysis of the European Medicines Agency/European Medicines Agency adverse drug reactions’ database. J Clin Psychopharmacol. 2018;38(1):72–79. doi:10.1097/JCP.0000000000000814
   PubMed Web of Science ®Google Scholar
• Kim S, Lee G, Kim E, Jung H, Chang J. Quetiapine misuse and abuse: is it an atypical paradigm of drug seeking behavior? J Res Pharm Pract. 2017;6(1):12–15. doi:10.4103/2279-042X.200987
   Web of Science ®Google Scholar
• Montebello ME, Brett J. Misuse and associated harms of quetiapine and other atypical antipsychotics. Curr Top Behav Neurosci. 2017;34:125–139. doi:10.1007/7854_2015_424
   PubMedGoogle Scholar
• Evoy KE, Teng C, Encarnacion VG, et al. Comparison of quetiapine abuse and misuse reports to the FDA adverse event reporting system with other second-generation antipsychotics. Subst Abuse. 2019;13:1178221819844205. doi:10.1177/1178221819844205
   Web of Science ®Google Scholar
• Smith SM, Dart RC, Katz NP, et al. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain. 2013;154(11):2287–2296. doi:10.1016/j.pain.2013.05.053
   PubMed Web of Science ®Google Scholar
• NIDA. The science of drug use and addiction: the basics. national institute on drug abuse website; June 25, 2020. Available from: https://www.drugabuse.gov/publications/media-guide/science-drug-use-addiction-basics. Accessed April 30, 2021.
   Google Scholar
• Klein-Schwartz W, Schwartz EK, Anderson BD. Evaluation of quetiapine abuse and misuse reported to poison centers. J Addict Med. 2014;8(3):195–198. doi:10.1097/ADM.0000000000000020
   Web of Science ®Google Scholar
• Klein L, Bangh S, Cole JB. Intentional recreational abuse of quetiapine compared to other second-generation antipsychotics. West J Emerg Med. 2017;18(2):243–250. doi:10.5811/westjem.2016.10.32322
   PubMed Web of Science ®Google Scholar
• Fischer BA, Boggs DL. The role of antihistaminic effects in the misuse of quetiapine: a case report and review of the literature. Neurosci Biobehav Rev. 2010;34(4):555–558. doi:10.1016/j.neubiorev.2009.11.003
   PubMed Web of Science ®Google Scholar
• Vento AE, Kotzalidis GD, Cacciotti M, et al. Quetiapine abuse fourteen years later: where are we now? A systematic review. Subst Use Misuse. 2020;55(2):304–313. doi:10.1080/10826084.2019.1668013
   PubMed Web of Science ®Google Scholar
• Atkin T, Comai S, Gobbi G. Drugs for insomnia beyond benzodiazepines: pharmacology, clinical applications, and discovery. Pharmacol Rev. 2018;70(2):197–245. doi:10.1124/pr.117.014381
   PubMed Web of Science ®Google Scholar
• Wick JY. The history of benzodiazepines. Consult Pharm. 2013;28(9):538–548. doi:10.4140/TCP.n.2013.538
   PubMedGoogle Scholar
• Schifano F, Chiappini S, Corkery JM, Guirguis A. An insight into Z-drug abuse and dependence: an examination of reports to the European Medicines Agency Database of suspected adverse drug reactions. Int J Neuropsychopharmacol. 2019;22(4):270–277. doi:10.1093/ijnp/pyz007
   PubMed Web of Science ®Google Scholar
• Gjerden P, Bramness JG, Tvete IF, Slørdal L. The antipsychotic agent quetiapine is increasingly not used as such: dispensed prescriptions in Norway 2004–2015. Eur J Clin Pharmacol. 2017;73(9):1173–1179. doi:10.1007/s00228-017-2281-8
   Web of Science ®Google Scholar
• Debernard KAB, Frost J, Roland PH. Quetiapine is not a sleeping pill. Tidsskr nor Laegeforen. 2019;139(13). English, Norwegian. doi: 10.4045/tidsskr.19.0205. PMID: 31556541
   Web of Science ®Google Scholar
• Kearns MA, Hawley KM. Predictors of polypharmacy and off-label prescribing of psychotropic medications: a national survey of child and adolescent psychiatrists. J Psychiatr Pract. 2014;20(6):438–447. doi:10.1097/01.pra.0000456592.20622.45
   PubMed Web of Science ®Google Scholar
• Reuss CF, Hasselstrøm JB, Linnet K, et al. Increased risk of fatal intoxication and polypharmacy among psychiatric patients at death. J Forensic Sci. 2021;66(1):255–264. doi:10.1111/1556-4029.14586
   Web of Science ®Google Scholar
• Baandrup L. Polypharmacy in schizophrenia. Basic Clin Pharmacol Toxicol. 2020;126(3):183–192. doi:10.1111/bcpt.13384
   PubMed Web of Science ®Google Scholar
• Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230. doi:10.1186/s12877-017-0621-2
   PubMed Web of Science ®Google Scholar
• Ventola CL. Big data and pharmacovigilance: data mining for adverse drug events and interactions. P T. 2018;43(6):340–351.
   PubMedGoogle Scholar
• Stokes CL, Schjøtt J. Disproportionality analysis for identification of drug safety signals in a database shared by the Norwegian network of drug information centres (RELIS). Eur J Clin Pharmacol. 2019;75(10):1469–1470. doi:10.1007/s00228-019-02717-x
   Web of Science ®Google Scholar
• Schjøtt J. Benefits of a national network of drug information centres: RELIS. Eur J Clin Pharmacol. 2017;73(1):125–126. doi:10.1007/s00228-016-2129-7
   Web of Science ®Google Scholar
• Schjøtt J, Bergman J. Joint medicine-information and pharmacovigilance services could improve detection and communication about drug-safety problems. Drug Healthc Patient Saf. 2014;6:89–92. doi:10.2147/DHPS.S63680
   Google Scholar
• Schjøtt J, Reppe LA, Roland PD, Westergren T. A question-answer pair (QAP) database integrated with websites to answer complex questions submitted to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive study. BMJ Open. 2012;2(2):e000642. doi:10.1136/bmjopen-2011-000642
   Web of Science ®Google Scholar
• World Health Organization. ICD-10 online versions. F10-F19 Mental and behavioural disorders due to psychoactive substance use. Available from: https://www.who.int/classifications/icd/icdonlineversions/en/. Accessed April 30, 2021.
   Google Scholar
• Gjerden P, Bramness JG, Slørdal L. Kvetiapin brukes for mye [Quetiapine is used too much]. Tidsskr nor Legeforen. 2018:138. Norwegian. doi:10.4045/tidsskr.18.0535
   Google Scholar
• Waal H, Vold JH, Skurtveit SO. Quetiapine abuse - myth or reality? Tidsskr nor Laegeforen. 2020;140(12). English, Norwegian. doi:10.4045/tidsskr.20.0059
   Web of Science ®Google Scholar
• Driot D, Jouanjus E, Oustric S, Dupouy J, Lapeyre-Mestre M. Patterns of gabapentin and pregabalin use and misuse: results of a population‐based cohort study in France. Br J Clin Pharmacol. 2019;85(6):1260–1269. doi:10.1111/bcp.13892
   PubMed Web of Science ®Google Scholar